Bio-Rad Labs (BIO) Misses Q2 EPS by 52c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $288.71 +1.71%
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
CCEL, SLP, TMQ, More
Revenue Growth %: -4.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $0.61, $0.52 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $516.8 million versus the consensus estimate of $497.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman lowers Mattel rating to Sell on macro and execution risks; shares dip
- Applied Materials surges as CEO signals multi-year chip boom
- Donerail urges Beazer Homes board to engage with DFH's $32 offer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
